Nuclear medicine vendor SMV of Twinsburg, OH, has announced that

the Food and Drug Administration has issued 510(k) clearance for

its transmission attenuation correction (TAC) protocol. TAC is

designed for SMV's Vision DST and Vision DST-XL variable-angle

 CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Nuclear medicine vendor SMV of Twinsburg, OH, has announced thatthe Food and Drug Administration has issued 510(k) clearance forits transmission attenuation correction (TAC) protocol. TAC isdesigned for SMV's Vision DST and Vision DST-XL

SMV's attenuation correction cleared